ZIPRASIDONE-ZP ziprasidone (as hydrochloride) 20 mg capsule blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

ziprasidone hydrochloride, Quantity: 21.72 mg (Equivalent: ziprasidone, Qty 20 mg)

Verfügbar ab:

Medis Pharma Pty Ltd

INN (Internationale Bezeichnung):

Ziprasidone hydrochloride

Darreichungsform:

Capsule, hard

Zusammensetzung:

Excipient Ingredients: Gelatin; pregelatinised maize starch; indigo carmine; magnesium stearate; colloidal anhydrous silica; titanium dioxide; croscarmellose sodium; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; Shellac; strong ammonia solution; ethanol absolute; iron oxide black

Verabreichungsweg:

Oral

Einheiten im Paket:

60

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy;,as monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar I disorder.

Produktbesonderheiten:

Visual Identification: size 4 capsule: white body, blue cap; "Z20" printed on capsule body; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2015-03-05